Cytori Therapeutics Inc : Cytori reports fourth quarter and full year 2016 business and financial results . Q4 loss per share $0.24 . Q4 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S . Cytori Therapeutics - Expects 2017 operating cash burn to be higher than 2016, primarily due to development of assets acquired from Azaya Therapeutics . Cytori Therapeutics - Q4 2016 total revenues were $3.0 million compared to $3.4 .Cytori Therapeutics Inc - Operating cash burn forecasted to be within a range of $26 million to $29 million for 2017.
Autek China Inc <300595.SZ> : Says net profit for FY 2017 Q1 to increase by 15.43 percent to 41.66 percent, or to be 22 million yuan to 27 million yuan, compared to net profit of FY 2016 Q1 (19.1 million yuan) .Says steady growth in core business as main reason for the forecast.
Excelsior Medical Co Ltd <4104.TW>: Says it will merge with its wholly owned subsidiary and the subsidiary will dissolve after merger .Says the subsidiary is engaged in wholesale and retail of precision instruments.
Guangzhou Wondfo Biotech Co Ltd <300482.SZ> : Sees Q1 FY 2017 net profit to increase by 10 percent to 40 percent, or to be 28.8 million yuan to 36.6 million yuan . Says Q1 FY 2016 net profit was 26.1 million yuan .The reasons for the forecast are stable development of main business and increased sales revenue in both cosmetic and overseas market.
William Demant : 2016 revenue 12.00 billion Danish crowns ($1.71 billion) versus 12.00 billion crowns seen in Reuters poll . 2016 EBIT adjusted 2.13 billion crowns (Reuters poll 2.07 billion crowns) . Says record-high EBIT of 2.13 billion crowns supported by strong finish to year . Says strong revenue growth of 13 pct driven by successful Oticon Opn and retail activities . Guides for 2017 EBIT in range of 2.2-2.5 billion crowns before announced restructuring costs of around 200 million crowns .Aims at target gearing multiple of 1.5-2.0 measured as net interest-bearing debt (NIBD) relative to EBITDA.
Exactech Inc : Exactech 2016 revenue up 7 pct to $257.6 million, Q4'16 revenue increased 6 pct to $66.2 million . Sees Q1 2017 earnings per share $0.26 to $0.28 . Q4 loss per share $0.82 . Sees Q1 2017 revenue $66 million to $68 million . Sees FY 2017 revenue $264 million to $272 million . Q4 revenue rose 7 percent to $257.6 million . Sees FY 2016 adjusted earnings per share $1.18 excluding items . Exactech Inc - on an adjusted basis diluted EPS target is $0.30-$0.32 for Q1 of 2017 . Exactech Inc sees FY 2017 GAAP earnings per share $1.20-$1.28 .Exactech Inc - during Q1 of 2017, co is anticipating an additional $0.9 million in charges related to divestiture of spine assets.
Japan's Olympus Corp <7733.T>, Terumo Corp <4543.T>: Olympus says to sell its entire 2.48 pct stake in Terumo back to Terumo . Olympus says to post 23 billion yen ($205 million) gain on sale . Terumo says will sell its 1.63 pct stake in Olympus by March 2017 .Olympus, Terumo say they will continue their business alliance.
Exactech Inc : Exactech announces divestiture of spine assets and restructuring charges . Exactech Inc - terms of transaction were not released . Exactech Inc says expects 2017 revenue to be in range of $264 - $272 million . Exactech - restructuring will result in a pre-tax charge to 2016 earnings in range of $15-17 million . Exactech says restructuring of its spine and biologics business segment including divestiture of its spine products business . Sees FY 2017 earnings per share $1.24 to $1.32 .Fy2017 earnings per share view $1.32, revenue view $271.1 million -- Thomson Reuters I/B/E/S.
Easywell Biomedical Inc <1799.TWO>:Says it resolved to liquidate its Shenzhen-based medical equipment unit.